Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Frye

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cell Reports. Medicine|January 18, 2023
Abortion bans and their impacts: A view from the United StatesLaura J Frye, Beverly Winikoff
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 16, 2014
Claims of misoprostol use based on blood sampling should be viewed with skepticismLaura J Frye, Beverly Winikoff, Karen Meckstroth
Contraception|December 3, 2014
What happens when we routinely give doxycycline to medical abortion patients?Laura J Frye, Erica Chong, Beverly Winikoff, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|April 23, 2016
A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routesLaura J Frye, Meagan E Byrne, Beverly Winikoff
Contraception|February 8, 2020
A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countriesLaura J Frye, Catherine Kilfedder, Jennifer Blum, et al.
Sexual and Reproductive Health Matters|November 1, 2021
A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globallyJill Durocher, Catherine Kilfedder, Laura J Frye, et al.
Contraception|July 6, 2015
A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.SErica Chong, Laura J Frye, Jen Castle, et al.
Biomarkers in Medicine|April 11, 2023
PAPP-A as a screening tool for assessment of gestational age before medication abortion in an intended-use populationLaura J Frye, Irina A Buhimschi, Elizabeth G Raymond, et al.
The Journal of Applied Laboratory Medicine|July 30, 2021
Analytical Comparison of Pregnancy-Associated Plasma Protein-A (PAPP-A) Immunoassays for Biochemical Determination of Gestational AgeIrina A Buhimschi, Guomao Zhao, Yara El Helou, et al.
BMC Research Notes|October 28, 2017
Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostolJames Ditai, Laura J Frye, Jill Durocher, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cell Reports. Medicine|January 18, 2023
Abortion bans and their impacts: A view from the United StatesLaura J Frye, Beverly Winikoff
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 16, 2014
Claims of misoprostol use based on blood sampling should be viewed with skepticismLaura J Frye, Beverly Winikoff, Karen Meckstroth
Contraception|December 3, 2014
What happens when we routinely give doxycycline to medical abortion patients?Laura J Frye, Erica Chong, Beverly Winikoff, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|April 23, 2016
A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routesLaura J Frye, Meagan E Byrne, Beverly Winikoff
Contraception|February 8, 2020
A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countriesLaura J Frye, Catherine Kilfedder, Jennifer Blum, et al.
Sexual and Reproductive Health Matters|November 1, 2021
A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globallyJill Durocher, Catherine Kilfedder, Laura J Frye, et al.
Contraception|July 6, 2015
A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.SErica Chong, Laura J Frye, Jen Castle, et al.
Biomarkers in Medicine|April 11, 2023
PAPP-A as a screening tool for assessment of gestational age before medication abortion in an intended-use populationLaura J Frye, Irina A Buhimschi, Elizabeth G Raymond, et al.
The Journal of Applied Laboratory Medicine|July 30, 2021
Analytical Comparison of Pregnancy-Associated Plasma Protein-A (PAPP-A) Immunoassays for Biochemical Determination of Gestational AgeIrina A Buhimschi, Guomao Zhao, Yara El Helou, et al.
BMC Research Notes|October 28, 2017
Achieving community-based postpartum follow up in eastern Uganda: the field experience from the MamaMiso Study on antenatal distribution of misoprostolJames Ditai, Laura J Frye, Jill Durocher, et al.
Pageof 2